Bangladesh vs Israel: Previously treated cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Israel
100.0%
in 2024
Bangladesh rank
1st
Israel rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bangladesh
- Israel
How they compare
Bangladesh currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2010 it was Israel ahead.
Bangladesh ranks 1st and Israel ranks 1st of 180 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 46.3% | 59.6% | 13.3% | Israel |
| 2020s | 96.0% | 100.0% | 4.0% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bangladesh or Israel?
- Bangladesh, at 100.0% against 100.0% in Israel as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bangladesh and Israel?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Israel?
- 14 years are reported by both, from 2010 to 2024.
- How do Bangladesh and Israel rank globally for previously treated cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Israel ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.